Osteopontin and Cancer: Insights into Its Role in Drug Resistance

被引：17
|
作者：
Hao, Chengcheng [1 ,2 ]
Lane, Jane [2 ]
Jiang, Wen G. [2 ]
机构：
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Oncol, Beijing 100038, Peoples R China
[2] Cardiff Univ, Div Canc & Genet, Cardiff China Med Res Collaborat, Sch Med, Heath Pk, Cardiff CF14 4XN, Wales
来源：
BIOMEDICINES | 2023年 / 11卷 / 01期
关键词：
osteopontin; cancer; drug resistance; molecular mechanism; LUNG-CANCER; EPIGENETIC MODIFICATIONS; EXPRESSION; CELLS; AUTOPHAGY; CISPLATIN; SENSITIVITY; BIOMARKER; HETEROGENEITY; MECHANISMS;
D O I：
10.3390/biomedicines11010197
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Cancer is one of the leading causes of mortality worldwide. Currently, drug resistance is the main obstacle in cancer treatments with the underlying mechanisms of drug resistance yet to be fully understood. Osteopontin (OPN) is a member of the integrin binding glycophosphoprotein family that is overexpressed in several tumour types. It is involved in drug transport, apoptosis, stemness, energy metabolism, and autophagy, which may contribute to drug resistance. Thus, understanding the role of OPN in cancer drug resistance could be important. This review describes the OPN-based mechanisms that might contribute to cancer drug resistance, demonstrating that OPN may be a viable target for cancer therapy to reduce drug resistance in sensitive tumours.
引用
收藏
页数：18
相关论文
共 50 条
  • [1] Chrysin and its emerging role in cancer drug resistance
    Kasala, Eshvendar Reddy
    Bodduluru, Lakshmi Narendra
    Barua, Chandana C.
    Gogoi, Ranadeep
    CHEMICO-BIOLOGICAL INTERACTIONS, 2015, 236 : 7 - 8
  • [2] Autophagy: New Insights into Its Roles in Cancer Progression and Drug Resistance
    Nawrocki, Steffan T.
    Wang, Wei
    Carew, Jennifer S.
    CANCERS, 2020, 12 (10)
  • [3] Insights on the Role of Polyphenols in Combating Cancer Drug Resistance
    Farhan, Mohd
    BIOMEDICINES, 2023, 11 (06)
  • [4] Emerging role of competing endogenous RNA in lung cancer drug resistance
    Wu, Shijie
    Luo, Ting
    Lei, Xiaoyong
    Yang, Xiaoyan
    JOURNAL OF CHEMOTHERAPY, 2024, 36 (07) : 546 - 565
  • [5] Role of osteopontin in cancer development and treatment
    Yan, Zhihua
    Hu, Xue
    Tang, Bin
    Deng, Fengmei
    HELIYON, 2023, 9 (10)
  • [6] Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer
    Zhang, Linxiang
    Zhang, Xueying
    Shi, Yan
    Ni, Yuhan
    Fei, Jiaojiao
    Jin, Zhixin
    Li, Wenjuan
    Wang, Xiaojing
    Wu, Nan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [7] THE ROLE OF OSTEOPONTIN AND ITS RECEPTOR IN MENINGIOMA DEVELOPMENT AND PROGRESSION
    Li, H. Z.
    Gong, H. D.
    Wang, C.
    Li, J. K.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (01) : 69 - 74
  • [8] Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance
    Panda, Shikshya S.
    Sahoo, Rajeev K.
    Patra, Sambit K.
    Biswal, Stuti
    Biswal, Bijesh K.
    DRUG DISCOVERY TODAY, 2024, 29 (08)
  • [9] Role of osteopontin in the pathophysiology of cancer
    Shevde, Lalita A.
    Samant, Rajeev S.
    MATRIX BIOLOGY, 2014, 37 : 131 - 141
  • [10] Dual Role of Mitophagy in Cancer Drug Resistance
    Yan, Chen
    Li, Tao-Sheng
    ANTICANCER RESEARCH, 2018, 38 (02) : 617 - 621
12345